# Immune Responses in Hepatocellular Carcinoma Patients After Treatment With Direct Acting Antiviral Drugs

> **NCT03602703** · — · COMPLETED · sponsor: **Assiut University** · enrollment: 42 (actual)

## Conditions studied

- Drug-Induced Liver Injury

## Interventions

- **DIAGNOSTIC_TEST:** Flow cytometry and Western Blot analysis

## Key facts

- **NCT ID:** NCT03602703
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-01
- **Primary completion:** 2019-09-01
- **Final completion:** 2019-09-01
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2020-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03602703

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03602703, "Immune Responses in Hepatocellular Carcinoma Patients After Treatment With Direct Acting Antiviral Drugs". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03602703. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*